Migraine does not affect cognitive decline: results from the Maastricht aging study

Area of Science:

• Neurology
• Cognitive Science
• Epidemiology

Background:

• Migraine is a common neurological disorder.
• Its long-term effects on cognitive function remain unclear.
• Understanding migraine's impact on cognition is crucial for patient care.

Purpose of the Study:

• To investigate the longitudinal effects of migraine on cognitive performance.
• To assess the influence of migraine-related pharmacotherapy on cognition.
• To determine if migraine is a risk or protective factor for cognitive decline.

Main Methods:

• A longitudinal population-based study involving 99 migraineurs and 1724 healthy controls.
• Cognitive testing included Mini Mental State Examination, memory recall, and processing speed at baseline and after 6 years.
• Generalized Estimating Equations analyses were used to evaluate the effects of migraine and medication use on cognitive change.

Main Results:

• Migraine headaches showed no significant effect on any cognitive measures.
• The use of migraine medication also had no discernible impact on cognitive performance.
• No differences in cognitive change over time were observed between migraineurs and controls.

Conclusions:

• Migraine headaches are not associated with cognitive dysfunction or deterioration over time.
• Migraine-related medication use does not appear to be a risk or protective factor for cognitive decline.
• This study provides no evidence linking migraine status or treatment to long-term cognitive changes.